Acute Promyelocytic Leukemia Cells (APLC)
[Edit]Acute promyelocytic leukemia (APML, APL) is the M3 subtype of acute myelogenous leukemia (AML), a cancer of the white blood cells. In APL, there is an abnormal accumulation of immature granulocytes called promyelocytes. The disease is characterized by a chromosomal translocation involving the retinoic acid receptor alpha (RARα or RARA) gene and is distinguished from other forms of AML by its responsiveness to all-trans retinoic acid (ATRA; also known as tretinoin) therapy.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Cells | n/a | Acute Promyelocytic Leukemia Cells (APLC) | Primary Cells Customized Service Offer |
Extracts | n/a | Extract of Acute Promyelocytic Leukemia Cells (APLC) | Total Protein/DNA/RNA Extract Customized Service Offer |
Mediums | n/a | Medium for Acute Promyelocytic Leukemia Cells (APLC) (If Necessary) | Cell Culture Medium Customized Service Offer |
Organism species: Mus musculus (Mouse)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Cells | n/a | Acute Promyelocytic Leukemia Cells (APLC) | Primary Cells Customized Service Offer |
Extracts | n/a | Extract of Acute Promyelocytic Leukemia Cells (APLC) | Total Protein/DNA/RNA Extract Customized Service Offer |
Mediums | n/a | Medium for Acute Promyelocytic Leukemia Cells (APLC) (If Necessary) | Cell Culture Medium Customized Service Offer |